Program Profile

Telehealth Pulmonary Rehabilitation for Patients With Severe Chronic Obstructive Pulmonary Disease

Author and Disclosure Information

 

References

Advanced balance training is not suitable due to an increased risk for falls. Without the presence of the PT, level of challenge/difficulty is somewhat limited for this telehealth supervision exercise program. In addition, visual and audio quality are necessary for the session. The patient and the therapists need to see each other clearly to ensure correct methods and forms of each exercise. Furthermore, rehearsal of technical skills with the therapists is very important because this population is older and often has limited computer skills. Any technical difficulty or failure can lead to undesirable situations (eg, anxiety episodes, worries, shortness of breath, upset), which compromise exercise performance during the session. Finally, a phone is needed as an alternative in case of a poor VVC connection.

Conclusion

COPD symptoms and complications greatly affect patients’ ability to perform daily activities, decrease QOL and functional ability, and result in extensive use of health services. Many patients have limited access to a PR program at hospitals or rehabilitation centers due to health conditions, lack of transportation, and/or family support. This home-based, interactive telehealth PR program can break down the geographic barriers, solve poor program accessibility, potentially increase the utilization of PR, and reduce the cost and travel required by the patients.

Acknowledgments
The Telehealth Pulmonary Rehabilitation Program was originally funded by the Veterans Health Administration VA ACCESS Program (AS, CL, HKH). We thank all the veterans for their time and effort in participating in this newly developed rehabilitation program.

Pages

Recommended Reading

FDA advisors recommend nintedanib for SSc interstitial lung disease
Federal Practitioner
COPD adds complexity to shared decision making for LDCT lung cancer screening
Federal Practitioner
Sepsis survivors’ persistent immunosuppression raises mortality risk
Federal Practitioner
Exposure to outdoor air pollutants linked to increased emphysema
Federal Practitioner
Study: Cardiac biomarkers predicted CV events in CAP
Federal Practitioner
FDA takes another swing at updating cigarette pack warnings
Federal Practitioner
Cardiovascular cost of smoking may last up to 25 years
Federal Practitioner
FDA approves Xenleta for community-acquired bacterial pneumonia treatment
Federal Practitioner
Impact of climate change on mortality underlined by global study
Federal Practitioner
First death from severe lung illness associated with vaping reported in Illinois
Federal Practitioner

Related Articles